In this study, through unsupervised clustering of the DDR-related expression profiles of HCC samples, we found that HCC patients could be divided into a DDR1 group (with low activation of DDR pathways) and a DDR2 group (with high activation of DDR pathways). The gene discussed is DDR1; the disease is hepatocellular carcinoma.